<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1020-3397</journal-id>
<journal-title><![CDATA[Eastern Mediterranean Health Journal]]></journal-title>
<abbrev-journal-title><![CDATA[East. Mediterr. health j.]]></abbrev-journal-title>
<issn>1020-3397</issn>
<publisher>
<publisher-name><![CDATA[Alexandria: WHO, Regional Office for the Eastern Mediterranean]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1020-33972007000500019</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Causes of low tetanus toxoid vaccination coverage in pregnant women in Lahore district, Pakistan]]></article-title>
<article-title xml:lang="fr"><![CDATA[Causes de la faiblesse de la couverture vaccinale antitétanique chez la femme enceinte dans le district de Lahore au Pakistan]]></article-title>
<article-title xml:lang="ar"><![CDATA[&#1571;&#1587;&#1576;&#1575;&#1576; &#1578;&#1614;&#1583;&#1614;&#1606;&#1617;&#1616;&#1610; &#1575;&#1604;&#1578;&#1594;&#1591;&#1610;&#1577; &#1576;&#1578;&#1591;&#1593;&#1610;&#1605; &#1575;&#1604;&#1581;&#1608;&#1575;&#1605;&#1604; &#1576;&#1604;&#1602;&#1575;&#1581; &#1584;&#1610;&#1601;&#1575;&#1606; &#1575;&#1604;&#1603;&#1586;&#1575;&#1586; &#1601;&#1610; &#1605;&#1602;&#1575;&#1591;&#1593;&#1577; &#1604;&#1575;&#1607;&#1608;&#1585; &#1601;&#1610; &#1576;&#1575;&#1603;&#1587;&#1578;&#1575;&#1606;]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hasnain]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sheikh]]></surname>
<given-names><![CDATA[N.H.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Allama Iqbal Medical College Department of Community Medicine ]]></institution>
<addr-line><![CDATA[Lahore ]]></addr-line>
<country>Pakistan</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2007</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2007</year>
</pub-date>
<volume>13</volume>
<numero>5</numero>
<fpage>1142</fpage>
<lpage>1152</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://eastern.mediterranean.scielo.org/scielo.php?script=sci_arttext&amp;pid=S1020-33972007000500019&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://eastern.mediterranean.scielo.org/scielo.php?script=sci_abstract&amp;pid=S1020-33972007000500019&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://eastern.mediterranean.scielo.org/scielo.php?script=sci_pdf&amp;pid=S1020-33972007000500019&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[To assess the causes of low tetanus toxoid (TT) vaccination coverage in pregnant women a mixture of quantitative and qualitative methods were adopted at the community, primary health care delivery and management levels in Lahore district, Pakistan. Out of a random sample of 362 women who had delivered during the previous 3 months, 87% recalled receiving 2 doses of TT. The main reasons for non-vaccination were poor knowledge about the importance of TT (32% of women) or the place and time to get vaccinated (18%). According to the managers and primary health care medical officers, the main reasons for low coverage were lack of awareness about the importance of vaccination among the public and misconceptions about TT vaccination (e.g. that it was a contraceptive).]]></p></abstract>
<abstract abstract-type="short" xml:lang="fr"><p><![CDATA[Afin d’évaluer les causes de la faiblesse de la couverture vaccinale antitétanique chez la femme enceinte, il a été fait appel à un assemblage de méthodes quantitatives et qualitatives aux niveaux de la collectivité, de la prestation des soins de santé primaires et de l’administration des programmes dans le district de Lahore au Pakistan. Sur un échantillon aléatoire de 362 femmes ayant accouché dans les 3 mois précédents, 87 % se sont souvenues avoir reçu 2 doses de vaccin antitétanique. Les principales raisons de cette absence de vaccination sont une méconnaissance de l’importance du vaccin antitétanique (32 % des enquêtées) ou du lieu et du moment auxquels se faire vacciner (18 %). Selon les administrateurs de programme et les médecins de soins de santé primaires, les principales causes de la faiblesse de cette couverture sont la non-prise de conscience par le public du rôle crucial de la vaccination et la mésinformation avec des idées préconçues prêtant par exemple une action contraceptive au vaccin antitétanique.]]></p></abstract>
<abstract abstract-type="short" xml:lang="ar"><p><![CDATA[&#1575;&#1587;&#1578;&#1582;&#1583;&#1605; &#1575;&#1604;&#1576;&#1575;&#1581;&#1579;&#1575;&#1606; &#1605;&#1580;&#1605;&#1608;&#1593;&#1577; &#1605;&#1578;&#1606;&#1608;&#1593;&#1577; &#1605;&#1606; &#1575;&#1604;&#1591;&#1585;&#1602; &#1575;&#1604;&#1603;&#1605;&#1610;&#1577; &#1608;&#1575;&#1604;&#1603;&#1610;&#1601;&#1610;&#1577; &#1605;&#1606; &#1571;&#1580;&#1604; &#1578;&#1602;&#1610;&#1600;&#1610;&#1605; &#1571;&#1587;&#1576;&#1575;&#1576; &#1578;&#1583;&#1606;&#1610; &#1578;&#1594;&#1591;&#1610;&#1577; &#1578;&#1591;&#1593;&#1610;&#1605; &#1575;&#1604;&#1581;&#1608;&#1575;&#1605;&#1604; &#1576;&#1604;&#1602;&#1575;&#1581; &#1584;&#1610;&#1601;&#1575;&#1606; &#1575;&#1604;&#1603;&#1586;&#1575;&#1586; &#1593;&#1604;&#1609; &#1575;&#1604;&#1605;&#1587;&#1578;&#1608;&#1609; &#1575;&#1604;&#1605;&#1580;&#1578;&#1605;&#1593;&#1610;&#1548; &#1608;&#1605;&#1587;&#1578;&#1608;&#1609; &#1605;&#1585;&#1575;&#1601;&#1602; &#1573;&#1610;&#1578;&#1575;&#1569; &#1575;&#1604;&#1585;&#1593;&#1575;&#1610;&#1577; &#1575;&#1604;&#1589;&#1581;&#1610;&#1577;&#1548; &#1608;&#1573;&#1583;&#1575;&#1585;&#1575;&#1578;&#1607;&#1575; &#1601;&#1610; &#1605;&#1606;&#1591;&#1602;&#1577; &#1604;&#1575;&#1607;&#1608;&#1585;&#1548; &#1576;&#1575;&#1603;&#1587;&#1578;&#1575;&#1606;. &#1608;&#1605;&#1606; &#1576;&#1610;&#1606; 362 &#1587;&#1610;&#1583;&#1577; &#1605;&#1579;&#1600;&#1617;&#1614;&#1604;&#1606; &#1593;&#1610;&#1606;&#1577; &#1593;&#1588;&#1608;&#1575;&#1574;&#1610;&#1577; &#1604;&#1587;&#1610;&#1583;&#1575;&#1578; &#1608;&#1604;&#1583;&#1606; &#1582;&#1604;&#1575;&#1604; &#1575;&#1604;&#1571;&#1588;&#1607;&#1585; &#1575;&#1604;&#1579;&#1604;&#1575;&#1579;&#1577; &#1575;&#1604;&#1587;&#1575;&#1576;&#1602;&#1577;&#1548; &#1584;&#1603;&#1585;&#1578; 87% &#1605;&#1606;&#1607;&#1606; &#1571;&#1606;&#1607;&#1606; &#1581;&#1589;&#1604;&#1606; &#1593;&#1604;&#1609; &#1580;&#1585;&#1593;&#1578;&#1610;&#1606; &#1605;&#1606; &#1604;&#1602;&#1575;&#1581; &#1584;&#1608;&#1601;&#1575;&#1606; &#1575;&#1604;&#1603;&#1586;&#1575;&#1586;. &#1608;&#1578;&#1600;&#1578;&#1605;&#1579;&#1617;&#1614;&#1604; &#1575;&#1604;&#1571;&#1587;&#1576;&#1575;&#1576; &#1575;&#1604;&#1585;&#1574;&#1610;&#1587;&#1610;&#1577; &#1604;&#1593;&#1583;&#1605; &#1578;&#1604;&#1602;&#1617;&#1616;&#1610; &#1575;&#1604;&#1578;&#1591;&#1593;&#1610;&#1605; &#1576;&#1607;&#1584;&#1575; &#1575;&#1604;&#1604;&#1602;&#1575;&#1581; &#1601;&#1610; &#1590;&#1593;&#1601; &#1573;&#1583;&#1585;&#1575;&#1603; &#1571;&#1607;&#1605;&#1610;&#1577; &#1604;&#1602;&#1575;&#1581; &#1584;&#1608;&#1601;&#1575;&#1606; &#1575;&#1604;&#1603;&#1586;&#1575;&#1586; (32% &#1605;&#1606; &#1575;&#1604;&#1587;&#1610;&#1583;&#1575;&#1578;)&#1548; &#1571;&#1608; &#1593;&#1583;&#1605; &#1605;&#1593;&#1585;&#1601;&#1577; &#1605;&#1603;&#1575;&#1606; &#1608;&#1608;&#1602;&#1578; &#1575;&#1604;&#1578;&#1591;&#1593;&#1610;&#1605; (18%). &#1608;&#1608;&#1601;&#1602;&#1575;&#1611; &#1604;&#1605;&#1575; &#1584;&#1603;&#1585;&#1607; &#1575;&#1604;&#1605;&#1583;&#1610;&#1585;&#1608;&#1606; &#1608;&#1575;&#1604;&#1605;&#1587;&#1572;&#1608;&#1604;&#1608;&#1606; &#1575;&#1604;&#1591;&#1576;&#1610;&#1608;&#1606; &#1601;&#1610; &#1605;&#1585;&#1575;&#1601;&#1602; &#1575;&#1604;&#1585;&#1593;&#1575;&#1610;&#1577; &#1575;&#1604;&#1589;&#1581;&#1610;&#1577; &#1575;&#1604;&#1571;&#1608;&#1604;&#1610;&#1577;&#1548; &#1601;&#1573;&#1606; &#1575;&#1604;&#1571;&#1587;&#1576;&#1575;&#1576; &#1575;&#1604;&#1585;&#1574;&#1610;&#1587;&#1610;&#1577; &#1604;&#1578;&#1583;&#1606;&#1610; &#1575;&#1604;&#1578;&#1594;&#1591;&#1610;&#1577; &#1607;&#1610; &#1594;&#1610;&#1575;&#1576; &#1575;&#1604;&#1608;&#1593;&#1610; &#1576;&#1571;&#1607;&#1605;&#1610;&#1577; &#1575;&#1604;&#1604;&#1602;&#1575;&#1581; &#1576;&#1610;&#1606; &#1575;&#1604;&#1580;&#1605;&#1607;&#1608;&#1585;&#1548; &#1608;&#1575;&#1604;&#1605;&#1601;&#1575;&#1607;&#1610;&#1605; &#1575;&#1604;&#1582;&#1575;&#1591;&#1574;&#1577; &#1581;&#1608;&#1604; &#1604;&#1602;&#1575;&#1581; &#1584;&#1608;&#1601;&#1575;&#1606; &#1575;&#1604;&#1603;&#1586;&#1575;&#1586; (&#1581;&#1610;&#1579; &#1610;&#1593;&#1578;&#1602;&#1583; &#1575;&#1604;&#1576;&#1593;&#1590; &#1571;&#1606;&#1607; &#1571;&#1581;&#1583; &#1608;&#1587;&#1575;&#1574;&#1604; &#1605;&#1606;&#1593; &#1575;&#1604;&#1581;&#1605;&#1604;).]]></p></abstract>
</article-meta>
</front><body><![CDATA[ <p align="right"><font face="verdana" size="2"><b>RESEARCH ARTICLES</b></font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="4"><b>Causes of low    tetanus toxoid vaccination coverage in pregnant women in Lahore district, Pakistan</b></font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Causes de la    faiblesse de la couverture vaccinale antitétanique chez la femme enceinte dans    le district de Lahore au Pakistan </b></font></p>     <p>&nbsp;</p>     <p align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>&#1571;&#1587;&#1576;&#1575;&#1576;    &#1578;&#1614;&#1583;&#1614;&#1606;&#1617;&#1616;&#1610; &#1575;&#1604;&#1578;&#1594;&#1591;&#1610;&#1577;    &#1576;&#1578;&#1591;&#1593;&#1610;&#1605; &#1575;&#1604;&#1581;&#1608;&#1575;&#1605;&#1604;    &#1576;&#1604;&#1602;&#1575;&#1581; &#1584;&#1610;&#1601;&#1575;&#1606; &#1575;&#1604;&#1603;&#1586;&#1575;&#1586;    &#1601;&#1610; &#1605;&#1602;&#1575;&#1591;&#1593;&#1577; &#1604;&#1575;&#1607;&#1608;&#1585;    &#1601;&#1610; &#1576;&#1575;&#1603;&#1587;&#1578;&#1575;&#1606;</b></font></p>     <p align="right">&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>S. Hasnain;    N.H. Sheikh</b></font></p>     ]]></body>
<body><![CDATA[<p align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#1587;&#1610;&#1605;&#1575;    &#1581;&#1587;&#1606;&#1610;&#1606;&#1548; &#1606;&#1575;&#1607;&#1610;&#1583;    &#1607;&#1605;&#1575;&#1610;&#1608;&#1606; &#1588;&#1610;&#1582;</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Department of Community    Medicine, Allama Iqbal Medical College, Lahore, Pakistan (Correspondence to    S. Hasnain: <a href="mailto:drseemahasnain@yahoo.com">drseemahasnain@yahoo.com</a>)</font></p>     <p>&nbsp;</p>     <p>&nbsp;</p> <hr size="1" noshade>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>ABSTRACT</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">To assess the causes    of low tetanus toxoid (TT) vaccination coverage in pregnant women a mixture    of quantitative and qualitative methods were adopted at the community, primary    health care delivery and management levels in Lahore district, Pakistan. Out    of a random sample of 362 women who had delivered during the previous 3 months,    87% recalled receiving 2 doses of TT. The main reasons for non-vaccination were    poor knowledge about the importance of TT (32% of women) or the place and time    to get vaccinated (18%). According to the managers and primary health care medical    officers, the main reasons for low coverage were lack of awareness about the    importance of vaccination among the public and misconceptions about TT vaccination    (e.g. that it was a contraceptive). </font></p> <hr size="1" noshade>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>RÉSUMÉ</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Afin d’évaluer    les causes de la faiblesse de la couverture vaccinale antitétanique chez la    femme enceinte, il a été fait appel à un assemblage de méthodes quantitatives    et qualitatives aux niveaux de la collectivité, de la prestation des soins de    santé primaires et de l’administration des programmes dans le district de Lahore    au Pakistan. Sur un échantillon aléatoire de 362 femmes ayant accouché dans    les 3 mois précédents, 87 % se sont souvenues avoir reçu 2 doses de vaccin antitétanique.    Les principales raisons de cette absence de vaccination sont une méconnaissance    de l’importance du vaccin antitétanique (32 % des enquêtées) ou du lieu et du    moment auxquels se faire vacciner (18 %). Selon les administrateurs de programme    et les médecins de soins de santé primaires, les principales causes de la faiblesse    de cette couverture sont la non-prise de conscience par le public du rôle crucial    de la vaccination et la mésinformation avec des idées préconçues prêtant par    exemple une action contraceptive au vaccin antitétanique.</font></p> <hr size="1" noshade>     <p align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&#1575;&#1604;&#1582;&#1604;&#1575;&#1589;&#1600;&#1577;</b></font></p>     <p align="right"> <font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#1575;&#1587;&#1578;&#1582;&#1583;&#1605;    &#1575;&#1604;&#1576;&#1575;&#1581;&#1579;&#1575;&#1606; &#1605;&#1580;&#1605;&#1608;&#1593;&#1577;    &#1605;&#1578;&#1606;&#1608;&#1593;&#1577; &#1605;&#1606; &#1575;&#1604;&#1591;&#1585;&#1602;    &#1575;&#1604;&#1603;&#1605;&#1610;&#1577; &#1608;&#1575;&#1604;&#1603;&#1610;&#1601;&#1610;&#1577;    &#1605;&#1606; &#1571;&#1580;&#1604; &#1578;&#1602;&#1610;&#1600;&#1610;&#1605;    &#1571;&#1587;&#1576;&#1575;&#1576; &#1578;&#1583;&#1606;&#1610; &#1578;&#1594;&#1591;&#1610;&#1577;    &#1578;&#1591;&#1593;&#1610;&#1605; &#1575;&#1604;&#1581;&#1608;&#1575;&#1605;&#1604;    &#1576;&#1604;&#1602;&#1575;&#1581; &#1584;&#1610;&#1601;&#1575;&#1606; &#1575;&#1604;&#1603;&#1586;&#1575;&#1586;    &#1593;&#1604;&#1609; &#1575;&#1604;&#1605;&#1587;&#1578;&#1608;&#1609; &#1575;&#1604;&#1605;&#1580;&#1578;&#1605;&#1593;&#1610;&#1548;    &#1608;&#1605;&#1587;&#1578;&#1608;&#1609; &#1605;&#1585;&#1575;&#1601;&#1602;    &#1573;&#1610;&#1578;&#1575;&#1569; &#1575;&#1604;&#1585;&#1593;&#1575;&#1610;&#1577;    &#1575;&#1604;&#1589;&#1581;&#1610;&#1577;&#1548; &#1608;&#1573;&#1583;&#1575;&#1585;&#1575;&#1578;&#1607;&#1575;    &#1601;&#1610; &#1605;&#1606;&#1591;&#1602;&#1577; &#1604;&#1575;&#1607;&#1608;&#1585;&#1548;    &#1576;&#1575;&#1603;&#1587;&#1578;&#1575;&#1606;. &#1608;&#1605;&#1606; &#1576;&#1610;&#1606;    362 &#1587;&#1610;&#1583;&#1577; &#1605;&#1579;&#1600;&#1617;&#1614;&#1604;&#1606;    &#1593;&#1610;&#1606;&#1577; &#1593;&#1588;&#1608;&#1575;&#1574;&#1610;&#1577;    &#1604;&#1587;&#1610;&#1583;&#1575;&#1578; &#1608;&#1604;&#1583;&#1606; &#1582;&#1604;&#1575;&#1604;    &#1575;&#1604;&#1571;&#1588;&#1607;&#1585; &#1575;&#1604;&#1579;&#1604;&#1575;&#1579;&#1577;    &#1575;&#1604;&#1587;&#1575;&#1576;&#1602;&#1577;&#1548; &#1584;&#1603;&#1585;&#1578;    87% &#1605;&#1606;&#1607;&#1606; &#1571;&#1606;&#1607;&#1606; &#1581;&#1589;&#1604;&#1606;    &#1593;&#1604;&#1609; &#1580;&#1585;&#1593;&#1578;&#1610;&#1606; &#1605;&#1606;    &#1604;&#1602;&#1575;&#1581; &#1584;&#1608;&#1601;&#1575;&#1606; &#1575;&#1604;&#1603;&#1586;&#1575;&#1586;.    &#1608;&#1578;&#1600;&#1578;&#1605;&#1579;&#1617;&#1614;&#1604; &#1575;&#1604;&#1571;&#1587;&#1576;&#1575;&#1576;    &#1575;&#1604;&#1585;&#1574;&#1610;&#1587;&#1610;&#1577; &#1604;&#1593;&#1583;&#1605;    &#1578;&#1604;&#1602;&#1617;&#1616;&#1610; &#1575;&#1604;&#1578;&#1591;&#1593;&#1610;&#1605;    &#1576;&#1607;&#1584;&#1575; &#1575;&#1604;&#1604;&#1602;&#1575;&#1581; &#1601;&#1610;    &#1590;&#1593;&#1601; &#1573;&#1583;&#1585;&#1575;&#1603; &#1571;&#1607;&#1605;&#1610;&#1577;    &#1604;&#1602;&#1575;&#1581; &#1584;&#1608;&#1601;&#1575;&#1606; &#1575;&#1604;&#1603;&#1586;&#1575;&#1586;    (32% &#1605;&#1606; &#1575;&#1604;&#1587;&#1610;&#1583;&#1575;&#1578;)&#1548;    &#1571;&#1608; &#1593;&#1583;&#1605; &#1605;&#1593;&#1585;&#1601;&#1577; &#1605;&#1603;&#1575;&#1606;    &#1608;&#1608;&#1602;&#1578; &#1575;&#1604;&#1578;&#1591;&#1593;&#1610;&#1605;    (18%). &#1608;&#1608;&#1601;&#1602;&#1575;&#1611; &#1604;&#1605;&#1575; &#1584;&#1603;&#1585;&#1607;    &#1575;&#1604;&#1605;&#1583;&#1610;&#1585;&#1608;&#1606; &#1608;&#1575;&#1604;&#1605;&#1587;&#1572;&#1608;&#1604;&#1608;&#1606;    &#1575;&#1604;&#1591;&#1576;&#1610;&#1608;&#1606; &#1601;&#1610; &#1605;&#1585;&#1575;&#1601;&#1602;    &#1575;&#1604;&#1585;&#1593;&#1575;&#1610;&#1577; &#1575;&#1604;&#1589;&#1581;&#1610;&#1577;    &#1575;&#1604;&#1571;&#1608;&#1604;&#1610;&#1577;&#1548; &#1601;&#1573;&#1606;    &#1575;&#1604;&#1571;&#1587;&#1576;&#1575;&#1576; &#1575;&#1604;&#1585;&#1574;&#1610;&#1587;&#1610;&#1577;    &#1604;&#1578;&#1583;&#1606;&#1610; &#1575;&#1604;&#1578;&#1594;&#1591;&#1610;&#1577;    &#1607;&#1610; &#1594;&#1610;&#1575;&#1576; &#1575;&#1604;&#1608;&#1593;&#1610;    &#1576;&#1571;&#1607;&#1605;&#1610;&#1577; &#1575;&#1604;&#1604;&#1602;&#1575;&#1581;    &#1576;&#1610;&#1606; &#1575;&#1604;&#1580;&#1605;&#1607;&#1608;&#1585;&#1548;    &#1608;&#1575;&#1604;&#1605;&#1601;&#1575;&#1607;&#1610;&#1605; &#1575;&#1604;&#1582;&#1575;&#1591;&#1574;&#1577;    &#1581;&#1608;&#1604; &#1604;&#1602;&#1575;&#1581; &#1584;&#1608;&#1601;&#1575;&#1606;    &#1575;&#1604;&#1603;&#1586;&#1575;&#1586; (&#1581;&#1610;&#1579; &#1610;&#1593;&#1578;&#1602;&#1583;    &#1575;&#1604;&#1576;&#1593;&#1590; &#1571;&#1606;&#1607; &#1571;&#1581;&#1583;    &#1608;&#1587;&#1575;&#1574;&#1604; &#1605;&#1606;&#1593; &#1575;&#1604;&#1581;&#1605;&#1604;).</font></p> <hr size="1" noshade>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Introduction</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Tetanus is a vaccine-preventable    disease that causes an annual total of 309 000 deaths &#91;<i>1</i>&#93;. Of particular    concern is maternal and neonatal tetanus (MNT) which represents a triple failure    of public health in terms of routine vaccinations, antenatal care and clean    delivery/umbilical cord care services. MNT is a swift and painful killer that    killed about 200 000 newborns in year 2000 &#91;<i>2</i>&#93;. The goal of MNT elimination    was declared jointly by the United Nations Children’s Fund (UNICEF), the World    Health Organization (WHO) and the United Nations Population Fund (UNFPA) along    with the establishment of a global fund for MNT elimination. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">MNT elimination    is defined as the achievement of less than 1 case of neonatal tetanus per 1000    live births annually in every district of a country in the world. The 3 key    strategies for achieving MNT elimination recommended by WHO/UNICEF/UNFPA are:    provision of at least 2 doses of tetanus toxoid (TT2) to all pregnant women    in high risk areas and 3 doses (TT3) to all women of childbearing age; promotion    of clean delivery services to all pregnant women and ensuring effective surveillance    for MNT.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">There is a renewed    momentum to achieve MNT elimination in the 57 countries which have not yet done    so. However, 90% of the neonatal deaths occur in 27 of the 57 countries &#91;<i>2</i>&#93;.    Pakistan is one of the 8 high-burden countries which account for about 73% of    neonatal tetanus deaths. These include Bangladesh, China, the Democratic Republic    of the Congo, Ethiopia, India, Nigeria, Pakistan and Somalia &#91;<i>3</i>&#93;. In    Pakistan, 22 000 neonatal deaths occur every year due to MNT &#91;<i>4</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In most developing    countries maternal TT vaccination is implemented as part of the routine vaccination    programme or implemented as a supplemental activity. However, large areas remain    underserved due to logistic, cultural, economic or other reasons. The 57 countries    were ranked in June 2000 into A, B and C classes. Class C countries need 3-4    years to phase in elimination activities &#91;<i>4</i>&#93;. Pakistan is included in    class C as more than 50% of the districts are at high risk for MNT because of    the limited health infrastructure which is indicated by 50% or lower coverage    of the third dose of diphtheria/pertussis/tetanus (DPT3), and serious manpower    and logistic constraints. There are extremely wide variations in TT vaccination    coverage from district to district in Pakistan even when they are in close proximity.    The delivery and acceptance of recommended vaccinations is an ongoing challenge    for health care providers and health care and public health systems. Reducing    the burden of immunizable diseases is thus an important aspect of human capital    development and a critical investment in the future of the country. The information    system of the Expanded Programme of Immunization (EPI) is reporting around 80%    of the coverage of children and about 38% of the TT2 coverage of pregnant mothers    in the province of Punjab &#91;<i>5</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">There are also    variations in TT coverage even across the provinces of Pakistan. In a study    conducted in Peshawar district of North West Frontier Province of Pakistan,    65% of women in urban areas were vaccinated, while in rural areas 60% were vaccinated.    Females in the urban area were older and had more knowledge regarding TT vaccination    than females in the rural areas. More women in the urban areas had made antenatal    care visits (79%) than those in rural area (50%) &#91;<i>6</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Despite considerable    resources being invested into the routine EPI programme in Pakistan, there is    no or very slow improvement in the TT coverage among the pregnant women with    the supplementary immunization activities. The routine reporting system of EPI    is supplemented by the coverage evaluation survey, the focus of which is basically    only on coverage. Little or no research has been done to analyse the causes    of low TT coverage of pregnant women n Pakistan. The present study therefore    focused on assessing the different causes of low vaccination coverage of TT2    in pregnant women in Lahore district in order to suggest ways of improving routine    vaccination coverage towards helping to eliminate neonatal tetanus.</font></p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Methods</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Study design    and setting</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">This was a cross-sectional    study in Lahore district, in 4 parts: (1) a household interview survey with    married women who had recently delivered; (2) focus group discussions (FGD)    with married women of child-bearing age, husbands and health workers; (3) individual    interviews with primary health care (PHC) centre medical officers; and (4) individual    interviews with managers of the EPI. Lahore is the provincial capital with a    total population of 6 318 475. The majority of the population is urban based,    with only 17.6% living in rural areas &#91;<i>7</i>&#93;. Lahore district is administratively    divided into 6 towns having 150 union councils. The study definition of adequate    vaccination was when a woman had received the second dose of TT (TT2).</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Instruments    and staff</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Four sets of questionnaires    were developed: (1) household survey form; (2) FGD guidelines; (3) PHC centre    survey instrument; and (4) questionnaire for individual interviews of managers.    </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">We selected 3 teams    of researchers, each having 2 members: 2 teams were allocated 17 union councils    for the household survey and the 3rd team was allocated 18 union councils. These    teams were also directed to interview the medical officer in charge of PHCs    if they worked within their union councils. Training of data collectors for    delivering the household and PHC questionnaires was followed by field testing    of questionnaires. Only female interviewers specially trained for this purpose    carried out the household interviews with women.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Household survey    of newly-delivered women</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Sample</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">A representative    sample of 362 married women was randomly selected for household interviews.    The criteria used for sample estimation was the population size of the district,    the reported prevalence of TT coverage and ± 5% worst expectable results. The    eligibility criteria were married women of child-bearing age (15-49 years) who    had delivered during the past 3 months between 17 October 2003 to 17 January    2004 after 28 weeks of gestation. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">A multi-stage stratified    random sampling technique was used for the identification of the households.    Lahore district was divided into 6 strata according to the administrative division    of towns. At the 1st stage of the sampling, 35% of the union councils (total    52) from each town were selected using a random number list from <i>Epi-Info</i>,    version 6.0 statistical package. During the 2nd stage of sampling, a list of    all villages/wards from the selected union councils during the first stage was    drawn up. Out of this list 1 village/ward was selected randomly from each union    council using a random number list. During the 3rd stage, from each village/ward    selected, a cluster of 7 households was selected randomly, except for 1 village    where 5 respondents were interviewed. To select each household, the researcher    stood at a central location in the cluster, e.g. the largest mosque or school,    and rotated a pencil; the direction of the sharpened end indicated the 1st household    to be visited. The 2nd household was the one nearest to the first. The 3rd household    was the one whose front door was closest to the front door of the household    just visited (i.e. on either side of the street). This was repeated until the    required number of women had been interviewed in the cluster.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>Data collection    </i> </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The questionnaire    was divided into 5 sections to collect information on the following topics:    social, demographic and economic characteristics of the woman; information about    her last pregnancy; her knowledge about TT vaccination and the reasons for non-vaccination.    The questions were closed-ended with possible options listed against each and    coded. The interviewers chose answers from the given options but if not listed,    the response was recorded as "other" with specific information. The women’s    responses were checked from their vaccination card which is a client-retained    record. At the start of interview the purpose of the survey was explained to    the interviewees and informed verbal consent was taken. The interviewees were    assured about the confidentiality of their identity. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>FGDs with women,    husbands and health workers</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Sample</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Each FGD contained    5-10 participants from the local community, comprising married women of child-bearing    age, husbands of the women, the local community health workers known as lady    health workers (LHW), traditional birth attendants and a vaccinator from the    area. The staff of the PHC centres helped in the selection of the participants,    except for the women and their spouses. All couples present in the health centre    at the start of FGD were included; women are usually accompanied by their husbands    when visiting to the PHC. The timing of FGDs was selected to be convenient for    the health care providers, i.e. at non-peak hours.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>Data collection</i></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">These discussions    were conducted by a social scientist accompanied by a medical doctor who recorded    the proceedings. A total of 6 FGDs were conducted, 1 in each town, within the    health centre premises. At the start of the discussion, the participants were    told about the objectives of holding the FGD and value of their views about    TT vaccination. The participants were told about the importance of their suggestions    for improving TT vaccination coverage. The moderator started the discussion    using guidelines prepared in advance. The discussion revolved around knowledge    about tetanus and its vaccination, reasons for not getting the vaccination and    suggestions for improvement of vaccination coverage. The information collected    was analysed by a social scientist using the standardized analytical methods    for qualitative data. The responses were analysed by type of respondent.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Interviews with    medical officers in charge of PHC centres</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>Sample</i></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">All the PHC facilities    which fell within the selected union councils were surveyed. In the urban areas    no PHC centre existed, but in rural areas, every union council has 1 PHC centre.    There were 10 PHC centres in the selected union councils so 10 medical officers    in charge were interviewed. The medical officer in charge is a medical doctor    who is responsible for providing medical care and management of a particular    health facility. </font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>Data collection</i></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The interview was    designed to gauge medical doctors’ opinions about the reasons for low TT coverage    at service delivery points. The following aspects of each PHC centres were explored    with an open-ended questionnaire: catchment area population; geographic accessibility;    availability of staff relevant to EPI vaccination; links with the outreach vaccination    teams; vaccination services at static centre; opinion about reasons for low    coverage of TT vaccination; and suggestions for the improvement of the TT coverage    of pregnant women.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Interviews with    EPI managers</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>Sample</i></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Interviews were    made with 5 key people who were directly responsible for EPI activities in the    district: the executive district health officer, district health officer, deputy    district health officer, district superintendent of vaccination, and an inspector    of vaccination.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>Data collection</i></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">An open-ended questionnaire    was used for this purpose. The interview was conducted by a medical doctor.    The main focus of the interview was on exploring reasons for low TT coverage    and suggestions for improvement. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Statistical    analysis</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The data from household    surveys was checked manually, entered into <i>SPSS</i> and screened for coding    errors. <i>SPSS</i> was used to calculate rates, proportions of coverage and    confidence intervals (CI). Contingency data tables were analysed with the chi-squared    test. <i>P</i> &lt; 0.05 was considered statistically significant. The analysis    of the qualitative data was done manually by a social scientist.</font></p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Results</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>TT coverage</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Of the 362 women    responding to the household survey, 314 (87%) reported receiving at least TT2    vaccination, but this percentage decreased with TT3 and onwards (<a href="#tab1">Table    1</a>). </font></p>     <p><a name="tab1"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/emhj/v13n5/a18tab01.gif"></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Most (99%) of the    respondents who claimed to have TT vaccination, could not produce the record    card. Out of those who received TT2, 263 (84%) had some level of education,    with only 16% completely uneducated. There was a significant association between    vaccination status and educational level as well as attending antenatal care    (yes/no) and number of antenatal care visits. The TT2 coverage increased with    the level of education. About 45% of respondents with matriculation educational    level or above had had TT2 (<i>P</i> &lt; 0.0001) (<a href="#tab2">Table 2</a>).    The TT2 coverage was greater among the respondents who had had antenatal care    as compared to those who did not (<a href="#tab2">Table 2</a>). Respondents    with 3+ antenatal visits had greater TT2 coverage than those with &lt; 3 visits    (<a href="#tab2">Table 2</a>). </font></p>     <p><a name="tab2"></a></p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p align="center"><img src="/img/revistas/emhj/v13n5/a18tab2.gif"></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Reasons for    low TT coverage</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>Household survey</i></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">When asked about    the reasons for not having TT vaccination, the women’s responses varied widely.    The most common reason (32%) was that the women did not know the importance    of the TT vaccination, followed by 18% who did not know the correct place or    time to get the vaccination. Other reasons are listed in <a href="#tab3">Table    3</a>. </font></p>     <p><a name="tab3"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/emhj/v13n5/a18tab3.gif"></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>Focus group    discussions</i></font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In the FGDs most    women confessed that they did not know about TT and its dangerous outcome. A    few women had only heard about its signs and symptoms from other women and believed    that these signs were due to evil look of devils, jinn and other evil creatures.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">More than 90% of    women mentioned that vaccinators and other workers had not visited their houses    and never asked for or given any information about TT, nor had they offered    any services. LHWs discussed vaccinations against tetanus for the children but    not for the women. All the women said that if they had been informed about TT    by the LHWs then they would have been vaccinated. A small number of women interviewed    (about 10%) mentioned that they were informed about TT by LHWs and got vaccinated    from adjacent health facilities. A few women mentioned that they did not have    time to get vaccinated due to the burden of work in the house and a few women    also mentioned that they made many visits at nearby health facilities but nobody    was present there to vaccinate them. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Some of the women    showed apprehension about TT being a contraceptive injection. A few women said    that mother-in-laws were a barrier to getting vaccinated due to jealousy or    desire to control daughter-in-laws. Older women consider vaccination of no value    because they had experience of giving birth to children without TT vaccination    and did not face a problem. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>PHC centre medical    officers</i></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The main reasons    given for low TT coverage by the 10 medical officers in charge of the PHC facilities    were lack of awareness regarding TT vaccination among the public, misconceptions/misbeliefs    about TT injection (e.g. that they cause abortions or infertility, or that they    are used for family planning, etc.) and behaviour of mother-in-laws and husbands.    Other reasons are listed in <a href="#tab4">Table 4</a>.</font></p>     <p><a name="tab4"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/emhj/v13n5/a18tab4.gif"></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>EPI managers</i></font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The most common    reasons for low coverage identified by the 5 EPI managers were lack of awareness    among the public regarding TT coverage and misconceptions/misbeliefs about TT    injections. Other reasons are listed in <a href="#tab5">Table 5</a>.</font></p>     <p><a name="tab5"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/emhj/v13n5/a18tab5.gif"></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Discussion</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The study was undertaken    to evaluate the TT coverage in the Lahore district of Pakistan and to understand    the reasons for low coverage at various levels. We examined the TT coverage    (from history and card) among 362 mothers who had delivered within the previous    3 months. Although TT2 coverage among these mothers was relatively high (87%),    and is much higher than the provincial coverage (62%) &#91;<i>8</i>&#93;, only 17% of    women achieved a complete series of 5 injections, which is well below the WHO    expected level of vaccination of 100% of the pregnant women &#91;<i>4</i>&#93;. Attempts    should continue to increase the coverage with special focus on the causes of    low coverage.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In this study,    attendance at antenatal care had a very strong effect on TT2 coverage. TT vaccination    is one of the important components of antenatal care and an increase in antenatal    visits by the pregnant women significantly increased the TT coverage. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The TT2 coverage    in the present study (87%) is higher than the third party evaluation conducted    in 2003 which reported 80% TT2 coverage (from history and card) in Lahore district    &#91;<i>8</i>&#93;. The most probable explanation of this difference of coverage could    be the different methodology and respondents. In the third party evaluation    the respondents were mothers having children 0-11 months of age and 30 clusters    were selected randomly, whereas in the present study the respondents were mothers    in the same age group who had delivered during the previous 3 months and multistage    random sampling technique was used to identify 52 clusters. Only 1% of the mothers    could produce the vaccination card as compared to 3% in the third party evaluation    &#91;<i>8</i>&#93;. The most probable reason for this difference could be logistical-the    interrupted and irregular supply of printed materials and vaccination cards.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The reliability    of women’s recall of their TT status can be questioned. However, pregnancy and    childbearing are special events to the mother and she can be expected to recall    important events related to each pregnancy. This is supported by a study in    the Central African Republic, a country facing major public health challenges    and resource constraints, part of the multiple indicator cluster survey. Among    222 mothers, weighted TT coverage based on mother’s recall was 74.4% and tetanus    antitoxin seroprevalence was 88.7% &#91;<i>2</i>&#93;. In another study conducted in    Matlab, rural Bangladesh, women’s re-collection of TT vaccination was compared    with carefully maintained records of TT dose and found to be good, but considerably    reduced if they had received more than 2 doses. Recollection was also reduced    if the dose was administered more than a year before questioning. Younger women,    with fewer children and with good vaccination status, tended to have a better    recollection of the number of doses received. These results suggest that maternal    recall may underestimate TT doses received a year before the date of questioning    &#91;<i>9</i>&#93;. </font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The most common    reason (32%) for inadequate TT vaccination reported by the women was that they    were not aware of the importance of TT vaccination and did not know where and    when to get the vaccination (18%). It is interesting to note that 6% of the    respondents thought that these injections had something to do with contraception    because these are provided by the government free of charge. During the focus    group discussions with local communities almost the same reasons for low TT    coverage were mentioned as in the household survey. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">If a proper awareness    campaign using all the available channels were launched, supported by a strengthening    of the vaccination delivery system, it might be possible to achieve 100% TT2    coverage of pregnant mothers. However, the underlying causes of low coverage-such    as lack of decision-making power of women, low women’s literacy rate and poor    attendance at antenatal care-need to be addressed in addition to the factors    significantly associated with vaccination coverage-such as education and antenatal    care services as shown by this study and other studies in Asia and elsewhere.    In a study at a hospital in Ankara, Turkey, the vaccinated women (18.9% with    at least 1 dose of TT) were younger, of lower parity and had attended more antenatal    care visits than the unvaccinated women &#91;<i>10</i>&#93;. In another study conducted    in Indonesia, mothers who had heard of TT were 1.54 times more likely to have    been immunized than those who did not, while mothers who knew the reason for    TT were 2.15 times more likely to have been immunized than those who did not,    and those who knew at least 1 of the tetanus symptoms were 1.86 times more likely    to have been immunized than those who did not, respectively controlling for    other variables. Furthermore, women who had antenatal care were 30 times more    likely to have been immunized than those who did not. Enhancing mothers’ knowledge    on tetanus is important to increase the coverage of TT &#91;<i>11</i>&#93;. Likewise,    in a study conducted in rural Bihar, India, it was concluded that the likelihood    of a pregnant women receiving 2 doses of TT vaccine was affected by factors    such as birth order, maternal education, prenatal care provider, household standard    of living, health care seeking decision-maker and service availability &#91;<i>12</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The individual    interviews with people responsible for management of the vaccination delivery    system and in charge of PHC facilities also showed that lack of awareness in    the community was the single most important reason for low TT coverage, in addition    to other issues related with management and service delivery such as de-motivated    health workers and vacant posts of the vaccination staff.. These issues also    need to be addressed, not only to achieve 100% TT2 coverage of the pregnant    women but also to improve the vaccination coverage of other vaccine-preventable    diseases. </font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Conclusions</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">It is encouraging    that 87% of the women interviewed were protected against tetanus in Lahore district    which is the capital of the province and is the focus of all health activities.    However, 13% of women remained unprotected against tetanus. The situation of    TT2 coverage in other parts of the province is likely to be worse than the capital    district. The major reasons for non-vaccination were lack of awareness among    the community, demotivated health workers and vacant posts of the vaccination    staff. The deep-rooted causes are likely to include low literacy levels and    low women’s empowerment. To achieve the 100% target of TT coverage, both short-term    and long-term interventions are needed.</font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Recommendations</b></font></p>     <blockquote>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">        Use a mass media campaign to create awareness among women, their husbands      and families about the importance of TT vaccination and the consequences of      not being vaccinated.</font></p>       ]]></body>
<body><![CDATA[<p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">        Create incentives for outreach workers to boost their morale.</font></p>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">           Train health care providers in interpersonal communication.</font></p>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">           Improve the monitoring and supervision of vaccination activities.</font></p>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">           Provide the equipment required for delivery of vaccination services to all      PHCs.</font></p>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">           Ensure that vacant positions for vaccination staff are filled.</font></p> </blockquote>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Acknowledgements</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The authors express    their sincere thanks to all the team members of the Department of Community    Medicine, especially Professor Shaheena Manzoor, Head of Department, for invaluable    help and encouragement during this study. We also thank Professor Sibit-ul-Hasnain,    Principal of Allama Iqbal Medical College, for providing time assistance and    cooperation. We are also very thankful to the district administration and the    communities for their cooperation during the conduction of the survey. Special    thanks to Dr Ayesha Humayun and Dr Mahanaz Anjum Qazi who assisted us in all    the phases of field work.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">This investigation    received technical and financial support from the joint WHO Eastern Mediterranean    Region (EMRO), Division of Communicable Diseases (DCD) and the WHO Special Program    for Research and Training in Tropical Diseases (TDR): the EMRO DCD/TDR Small    Grants Scheme for Operational Research in Tropical and Communicable Diseases.    </font></p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>References</b></font></p>     <!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1. Vandelaer J    et al. Tetanus in developing countries: an update on the Maternal and Neonatal    Tetanus Elimination Initiative. <i>Vaccine</i>, 2003, 21(24):3442-5.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=005176&pid=S1020-3397200700050001900001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2.   Deming MS    et al. Tetanus toxoid coverage as an indicator of serological protection against    neonatal tetanus. <i>Bulletin of the World Health Organization</i>, 2002, 80(9):696-703.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>3.   Eliminate    maternal and neonatal tetanus (MNT) by 2005 </i>&#91;online news&#93; (<a href="http://www.medicalnewstoday.com/medicalnews.php?newsid=12383" target="_blank">http://www.medicalnewstoday.com/medicalnews.php?newsid=12383</a>,    accessed 9 March 2007).</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>4.   Maternal    and neonatal tetanus elimination by 2005. Strategies for achieving and maintaining    elimination</i>. Geneva, WHO/UNICEF/UNFPA, 2000.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>5.   Annual    report. EPI coverage</i>. Lahore, Punjab, Directorate General of Health Services,    2001 and 2002.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">6.   Afridi NK    et al. Coverage and factors associated with tetanus toxoid vaccination status    among females of reproductive age in Peshawar. <i>Journal of the College of    Physicians and Surgeons of Pakistan</i>, 2005, 15(7):391-5.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>7.   District    population profile: Punjab</i>. Islamabad, Pakistan, Multi-donor Support Unit,    March 2002. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>8.   Expanded    Programme on Immunization: coverage evaluation survey 2003.</i> Lahore, Provincial    Health Department, Government of the Punjab, UNICEF/Contech International Health    Consultants, 2003.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">9.   De Francisco    A, Chakraborty J. Maternal recall of tetanus toxoid vaccination. <i>Annals of    tropical paediatrics</i>, 1996, 16(1):49-54.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">10.  Mara I et    al. Tetanus immunization in pregnant women: evaluation of maternal tetanus vaccination    status and factors affecting rate of vaccination coverage. <i>Public health</i>,    2001, 115(5):359-64.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">11.  Roosihermiatie    B, Nishiyama M, Nakae K. Factors associated with TT (tetanus toxoid) immunization    among pregnant women in Saparua, Maluku, Indonesia. <i>Southeast Asian journal    of tropical medicine and public health</i>, 2000, 31(1):91-5.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">12.  Thind A. Determinants    of tetanus toxoid immunization in pregnancy in rural Bihar. <i>Tropical doctor</i>,    2005, 35(2):75-7</font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> Received: 09/08/05;    accepted: 31/10/05 </font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Tetanus vaccine:    WHO position paper</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> In countries with    effective immunization programmes and good standards of hygiene, maternal and    neonatal tetanus (MNT) has been largely eliminated (&lt; 1 case per 1000 live    births at the district level). A remarkable reduction in the number of MNT cases    has also been achieved in many developing countries. Nonetheless, in 2004, an    estimated 40 million pregnant women were still in need of immunization against    birth-associated tetanus, and about 27 million children did not complete their    primary tetanus immunization series. The goals of tetanus control are primarily    (i) to eliminate MNT globally; and (ii) to achieve and sustain high coverage    of 3 doses of DTP and of appropriate booster doses in order to prevent tetanus    in all age groups.   </font></p>     ]]></body>
<body><![CDATA[<p align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Source:    Weekly epidemiological record, 2006, 20    <br>     (<a href="http://www.who.int/immunization/wer8120tetanus_May06_position_paper.pdf" target="_blank">http://www.who.int/immunization/wer8120tetanus_May06_position_paper.pdf</a>)</font></p>      ]]></body>
<REFERENCES></REFERENCES<back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vandelaer]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative]]></article-title>
<source><![CDATA[Vaccine]]></source>
<year>2003</year>
<volume>21</volume>
<numero>24</numero>
<issue>24</issue>
<page-range>3442-5</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
